JPMorgan Downgrades The Beauty Health Company (SKIN) to Underweight, 'hampered by execution challenges'

Go back to JPMorgan Downgrades The Beauty Health Company (SKIN) to Underweight, 'hampered by execution challenges'

BeautyHealth Reports Third Quarter 2023 Financial Results

November 13, 2023 4:10 PM EST

Revises financial guidance on lower-than-expected U.S. revenue and incurs restructuring charges for device upgrades

Delivers net sales of $97.4 million driven by double digit growth in APAC and EMEA

LONG BEACH, Calif.--(BUSINESS WIRE)-- The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2023. For the quarter, net sales of $97.4 million increased +10% year-over-year, on the strength of performance in Asia-Pacific, including China, and EMEA. The quarter was overshadowed by lower-than-expected U.S. revenue and... More

BeautyHealth Announces Leadership Transition

November 13, 2023 4:05 PM EST

Beauty Industry Veteran and BeautyHealth Director Marla Beck to Serve as Interim CEO, Succeeding Andrew Stanleick

LONG BEACH, Calif.--(BUSINESS WIRE)-- The BeautyHealth Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced that Andrew Stanleick will depart the Company as President & Chief Executive Officer and relinquish his Board seat, effective November 19, 2023. Current BeautyHealth Director Marla Beck will serve as Interim Chief Executive Officer while the Companys Board of Directors completes a formal search for a new CEO.

On behalf of the Board of Directors,... More